MENU
PTHS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Pelthos Therapeutics (PTHS) Earnings Date & Reports
Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens... Show more
A.I. Advisor
published Earnings
PTHS is expected to report earnings to fall 57.25% to -282 cents per share on November 12
Q3'26
Est.
$-2.83
Q2'26
Missed
by $6.11
Q1'26
Missed
by $2.58
Q4'25
Missed
by $6.33
The last earnings report on August 13 showed earnings per share of -661 cents, missing the estimate of -50 cents. With 79.80K shares outstanding, the current market capitalization sits at 71.59M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
What is a Good Financial Advisor?
Which Stock Screener is Right for You in 2023?
What are Credit Cards and Which Type of Credit Card is Right for You?
Economic Turmoil: Wall Street Braces for Impact as Federal Reserve Hesitates
Top Stocks in the Income Properties Group: Navigating the Real Estate Market
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
4020 Stirrup Creek Drive
Phone
+1 919 908-2400
Employees
92
Web
https://www.pelthos.com